Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis-Reference-Cited by-同舟云学术

Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis

Published:2022-02-18 Issue:6 Volume:49 Page:5117-5131
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Khan Hina,Ghori Fareeha Khalid,Ghani Uzma,Javed Aneela,Zahid Saadia^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-022-07223-5.pdf

Reference114 articles.

1. Banks WA (2015) The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun 44:1–8. https://doi.org/10.1016/j.bbi.2014.08.007

2. Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ (2014) Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology 83(11):1022–1024. https://doi.org/10.1212/WNL.0000000000000768

3. Chiurchiù V, van der Stelt M, Centonze D, Maccarrone M (2018) The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases. Prog Neurobiol 160:82–100. https://doi.org/10.1016/j.pneurobio.2017.10.007

4. Tullman MJ (2013) Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manage Care 19(2 Suppl):S15-20

5. Kamińska J, Koper OM, Piechal K, Kemona H (2017) Multiple sclerosis—etiology and diagnostic potential. Postepy Hig Med Dosw (Online) 71:551–563. https://doi.org/10.5604/01.3001.0010.3836

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytocannabinoids in neuromodulation: From omics to epigenetics;Journal of Ethnopharmacology;2024-08

2. Clinical outcome analysis of patients with multiple sclerosis – Analysis from the UK Medical Cannabis Registry;Multiple Sclerosis and Related Disorders;2024-07

3. Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists;ACS Central Science;2024-03-11

4. Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain;Function;2023-11-23

5. Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome;Frontiers in Psychiatry;2023-10-03